CAS: 1803171-55-2
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Ravulizumab REF: TM-T76867CAS: 1803171-55-2 | > 95% | 235,00 €~2.547,00 € | Mar 04 Mar 25 |
 | Ravulizumab REF: 3D-CLA1459CAS: 1803171-55-2 | - - - | A consultar | Vie 14 Mar 25 |
Ravulizumab
CAS:1803171-55-2
Ravulizumab (ALXN1210) is a humanized antibody for blocking complement activation, treating PNH, aHUS, and myasthenia …
Pureza:
> 95%
Forma y color:
Liquid
Peso molecular:
145.80 kDa
Ref: TM-T76867
| 1mg | 235,00 € | ||
| 5mg | 588,00 € | ||
| 10mg | 944,00 € | ||
| 25mg | 1.396,00 € | ||
| 50mg | 1.882,00 € | ||
| 100mg | 2.547,00 € |
Entrega estimada en Estados Unidos, el Martes 4 de Marzo de 2025
Ravulizumab
CAS:1803171-55-2
Anti-Complement component 5 humanized monoclonal antibody; paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome treatment
Ref: 3D-CLA1459
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Marzo de 2025
